Operational Disruption
Akums Reports Temporary Operational Disruption at Haridwar Manufacturing Sites
NSE
akums
BSE
544222
Akums Drugs and Pharmaceuticals Limited informed stock exchanges that certain manufacturing facilities in Haridwar were temporarily impacted due to labour unrest in the SIDCUL industrial area. The company stated that operations have been disrupted for the time being, while discussions are underway to normalize operations quickly.
PRICE-SENSITIVE TRIGGER
Event: Temporary disruption of manufacturing operations at Haridwar facilities
Type: Operational Disruption
Impact: Negative
Immediate Effect: Operations at some manufacturing sites in Haridwar have been temporarily disrupted due to labour unrest in the SIDCUL industrial area.
Key Metrics:
- No quantified financial impact disclosed yet
- Management stated impact assessment is currently under evaluation
- Operations affected at certain manufacturing sites in Haridwar
- Further operational updates to be shared in due course
Highlight:
- Manufacturing operations at select Haridwar facilities were temporarily disrupted due to labour unrest.
What Happened ?
Akums Drugs and Pharmaceuticals Limited informed exchanges that labour unrest in the SIDCUL industrial area of Haridwar on May 14, 2026 impacted operations at certain manufacturing sites. The company stated that the unrest resulted in temporary disruption of operations and immediate corrective measures are being taken to restore normal functioning.
Management also confirmed that local authorities are in discussions with workers to resolve the issue amicably and at the earliest.
key highlights
Operational Update:
- Labour unrest occurred in the SIDCUL industrial area, Haridwar
- Certain manufacturing sites of Akums were impacted
- Operations faced temporary disruption
- Management initiated active measures to normalize operations
- Local authorities are engaged in discussions with workers
- Company will provide further updates after assessing operational impact
Note:
- The company has not yet disclosed the extent of production loss, duration of disruption, or estimated financial implications.
Risk Analysis
Key Risks:
- Potential delay in manufacturing output
- Possible supply-chain disruption for customers
- Temporary impact on dispatches and inventory planning
- Labour-related operational uncertainty
Worst Case Scenario:
- If the labour unrest continues for an extended period, production disruptions could impact revenue visibility, customer deliveries, and operational efficiency.
Risk Level: Medium
Company Commentary
- The company stated that active measures are being taken to normalize operations
- Management and local authorities are in discussions with workers
- Akums said the issue is being addressed quickly and amicably
- Further assessment and updates will be shared in due course
Official Exchange Filing: Akums Drugs and Pharmaceuticals Limited